Do you have a regulatory issue involving the commercialization or sale of a medical device or drug? Are you seeking to clear a medical device or approve a drug in the US Food & Drug Administration (FDA), or in Europe (EMA), United Kingdom (MHRA), China (NMDA), Japan (PMDA), Health Canada, Australia (TGA), or India (DCGI)? Are you seeking a CPT code or developing a reimbursement strategy to ensure payment for your medical device, drug, diagnostic, or other regulated product?
If so, Torrey Pines Law Group may be able to help you. Our regulatory advisors, reimbursement specialists, and network of CROs and CMOs are experienced with defining commercialization strategies through international regulatory and reimbursement agencies. If you need an Orange County FDA regulatory advisor to help you with your international regulatory and reimbursement strategy, please contact us for our complimentary consultation to discuss your regulatory or reimbursement matter.
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Orange County FDA regulatory advisors - Irvine FDA regulatory counsel - FDA regulatory law firm - EMA, MHRA, NMDA, PMDA, Health Canada, TGA, DCGI - medical device approvals - medical device clearances - drug approvals - in vitro diagnostics approvals